Home
Be The Match BioTherapies

Be The Match BioTherapies Market Share Analysis for July 2026

NMDP BioTherapies designs solutions that accelerate your autologous or allogeneic cell and gene therapy development.

Industry: N/A

Domainbethematchbiotherapies.com

Year Founded2016

Employees501 - 1000

Annual Revenue$5M - $10M

Be The Match BioTherapies

Be The Match BioTherapies (including company regionals)

bethematchbiotherapies.com

See more website traffic and engagement information

Be The Match BioTherapies Revenue up to July 2026 is 5M - 10M

revenue generated by Be The Match BioTherapies top domains

Be The Match BioTherapies top domains revenue over 3 years

Revenue for Be The Match BioTherapies top domains

bethematchbiotherapies.com5M - 10M

See more with Sales Intelligence

Total visits to Be The Match BioTherapies's top domains

Understand Be The Match BioTherapies market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Be The Match BioTherapies's top domains

Analyze Be The Match BioTherapies engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Be The Match BioTherapies's top domains

See how Be The Match BioTherapies keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Be The Match BioTherapies top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Be The Match BioTherapies

These are the website technologies, by industry, used by Be The Match BioTherapies top domains

Advertising (10)

DoubleClick

Widget (6)

Twemoji

Marketing (4)

Google Marketing Platform

Conversion & Analytics (3)

Google Analytics

More Technologies

9

See all

News & Signals from Be The Match BioTherapies

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBethematchbiotherapies hired Christina Melief as Senior Scientific Advisor on Jul 25th '23.MINNEAPOLIS, MINN., July 25, 2023 – Underscoring its commitment to advance the cell therapy ecosystem, providing cures so all patients thrive, the National Marrow Donor Program® (NMDP)/Be The Match® announced that Christina Melief, PhD, joined the organization as Senior Scientific Advisor.

NewsBethematchbiotherapies partnered with Garudatx on May 24th '23.Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, today announced a working partnership with Garuda Therapeutics, a company working to create off-the-shelf, durable blood stem cell-based cellular therapies.

NewsChimeric Therapeutics Ltd partners with Bethematchbiotherapies.Chimeric Therapeutics Ltd (ASX:CHM) has teamed up with Be The Match BioTherapies to advance its CHM 1101 Chlorotoxin CAR T (CLTX CAR T) treatment candidate.